2,839
Views
20
CrossRef citations to date
0
Altmetric
Research Article

VITALITY-ALS, a phase III trial of tirasemtiv, a selective fast skeletal muscle troponin activator, as a potential treatment for patients with amyotrophic lateral sclerosis: study design and baseline characteristics

, , , , , , , & show all
Pages 259-266 | Received 04 Aug 2017, Accepted 19 Dec 2017, Published online: 06 Feb 2018